istock-515912196cbarnesphotography

cbarnesphotography / iStockphoto.com

15 January 2018Americas

US identifies shortcomings in China’s IP pharma sector

The US Department of Commerce (DOC) has said that there are “shortcomings” in China’s IP rights when it comes to the country’s pharmaceutical sector.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Trump shuts down manufacturing council following resignations

17 August 2017 US President Donald Trump has put an end to his manufacturing council after a series of resignations.

LSPN 2016: Trump’s TPP announcement is a ‘detriment’ to US companies

8 December 2016 President-elect Donald Trump’s announcement that he will withdraw the US from the Trans-Pacific Partnership is a “detriment” to US companies in terms of enforcing their patent rights in other jurisdictions.

More on this story

Trump shuts down manufacturing council following resignations

17 August 2017 US President Donald Trump has put an end to his manufacturing council after a series of resignations.

LSPN 2016: Trump’s TPP announcement is a ‘detriment’ to US companies

8 December 2016 President-elect Donald Trump’s announcement that he will withdraw the US from the Trans-Pacific Partnership is a “detriment” to US companies in terms of enforcing their patent rights in other jurisdictions.

More on this story

Trump shuts down manufacturing council following resignations

17 August 2017 US President Donald Trump has put an end to his manufacturing council after a series of resignations.

LSPN 2016: Trump’s TPP announcement is a ‘detriment’ to US companies

8 December 2016 President-elect Donald Trump’s announcement that he will withdraw the US from the Trans-Pacific Partnership is a “detriment” to US companies in terms of enforcing their patent rights in other jurisdictions.

More features

Life sciences leaders recognised at LSPN Awards USA 2025

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body

LSPN: Counsel grapple with AI’s impact on training and critical thinking

'Nothing can stand in the way of our work': Ukraine resumes IP system

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

ResMed voids sleep apnoea tech patent at PTAB